Ann: Dimerix to present at Melbourne Twilight Investor Briefing, page-8

  1. 318 Posts.
    lightbulb Created with Sketch. 96
    Great investor briefing, and the best part is, even this far into phase 3 we still have no
    Side effects, what a blessing for the patients and a huge bonus for Dimerix
    to still be able to say, our treatment for FSGS has no SIDE EFFECTS !
    Not every company trying to treat FSGS can say this, but we sure as heck can.

    I think one resident pest will get the message when he reads this lol
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
54.5¢
Change
-0.020(3.54%)
Mkt cap ! $327.0M
Open High Low Value Volume
56.5¢ 57.5¢ 53.8¢ $1.076M 1.936M

Buyers (Bids)

No. Vol. Price($)
2 23518 54.0¢
 

Sellers (Offers)

Price($) Vol. No.
55.0¢ 21500 1
View Market Depth
Last trade - 16.10pm 28/07/2025 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.